A multicentre, open-label, single-arm phase II trial of the efficacy and safety of sclerotherapy using 3% polidocanol foam to treat second-degree haemorrhoids (SCLEROFOAM)

BACKGROUND: The aim of the present study was to evaluate the efficacy and safety of 3% polidocanol foam for treating 2nd-degree haemorrhoids. METHODS: A multicentre, open-label, single-arm, phase 2 trial involving 10 tertiary referral centres for haemorrhodal disease (HD) was performed. Between Janu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallo, G., Pietroletti, R., Novelli, E., Sturiale, A., Tutino, R., Lobascio, P., Laforgia, R., Moggia, E., Pozzo, M., Roveroni, M., Bianco, V., Luc, A. Realis, Giuliani, A., Diaco, E., Naldini, G., Trompetto, M., Perinotti, R., Sammarco, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949823/
https://www.ncbi.nlm.nih.gov/pubmed/35334004
http://dx.doi.org/10.1007/s10151-022-02609-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949823/
https://www.ncbi.nlm.nih.gov/pubmed/35334004
http://dx.doi.org/10.1007/s10151-022-02609-w

Ejemplares similares